Defibrillators news | Breaking defibrillators news

News

Advertisers:

Boston Scientific gets FDA Acuity OK

...The Acuity lead also allows doctors to change the site of stimulation by reprogramming the device instead of having to perform another surgery, the company said.

Boston Scientific plans to launch the Acuity in July.

The device is the first new Boston Scientific product approved since the Food and Drug Administration lifted restrictions from a warning letter on Monday concerning the company's St.

Paul, Minn.

cardiac rhythm management device plant.

The lifting of restrictions also allowed the approval of five software upgrades for heart devices.

Boston Scientific shares added 2 cents to $16.02 in morning trading on the New York Stock Exchange.

This material may not be published, broadcast, rewritten, or redistributed.

Share on digg rawsugar You Might Like Boston Scientific mulls unit IPO Boston Scientific ratings reaffirmed Boston Scientific may spin off stake Boston Scientific's Taxus approved Pharmaceuticals and chemicals highlights to 09:10 GMT Comment on this Article Comment: Title: Name: Please Enter Here Search News Browse ABCmoney News Archive ...